MGLN - Magellan Health Stock Price, News & Analysis

$83.65 0.35 (0.42 %)
(As of 11/22/2017 04:00 PM ET)
Previous Close$83.30
Today's Range$83.20 - $84.00
52-Week Range$64.05 - $92.00
Volume66,900 shs
Average Volume139,729 shs
Market Capitalization$1.99 billion
P/E Ratio18.84
Dividend YieldN/A
Beta0.55

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).


Industry, Sector and Symbol:
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Sector: Medical
  • Symbol: NASDAQ:MGLN
  • CUSIP: 55907920
  • Web: www.magellanhealth.com
Debt:
  • Debt-to-Equity Ratio: 0.62%
  • Current Ratio: 2.28%
  • Quick Ratio: 2.21%
Price-To-Earnings:
  • Trailing P/E Ratio: 18.84
  • Forward P/E Ratio: 16.21
  • P/E Growth: 1.07
Sales & Book Value:
  • Annual Sales: $4.84 billion
  • Price / Sales: 0.42
  • Cash Flow: $9.32 per share
  • Price / Cash: 8.98
  • Book Value: $50.02 per share
  • Price / Book: 1.67
Profitability:
  • Trailing EPS: $3.79
  • Net Income: $77.87 million
  • Net Margins: 1.68%
  • Return on Equity: 9.20%
  • Return on Assets: 4.21%
Misc:
  • Employees: 9,700
  • Outstanding Shares: 24,040,000
 

Frequently Asked Questions for Magellan Health (NASDAQ:MGLN)

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) posted its quarterly earnings results on Wednesday, November, 1st. The company reported $1.64 EPS for the quarter, topping analysts' consensus estimates of $1.40 by $0.24. The company had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.49 billion. Magellan Health had a net margin of 1.68% and a return on equity of 9.20%. Magellan Health's revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.39 EPS. View Magellan Health's Earnings History.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY17 earnings guidance on Wednesday, November, 1st. The company provided EPS guidance of $5.45-5.86 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.13. The company issued revenue guidance of $5.75-5.85 billion, compared to the consensus revenue estimate of $5.80 billion.

Where is Magellan Health's stock going? Where will Magellan Health's stock price be in 2017?

4 Wall Street analysts have issued 12-month price objectives for Magellan Health's shares. Their predictions range from $69.00 to $94.00. On average, they anticipate Magellan Health's share price to reach $81.25 in the next year. View Analyst Ratings for Magellan Health.

What are Wall Street analysts saying about Magellan Health stock?

Here are some recent quotes from research analysts about Magellan Health stock:

  • 1. According to Zacks Investment Research, "Magellan Health Services is the country's leading behavioral managed care organization. Its customers include health plans, corporations and government agencies. " (10/4/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe mixed 4Q results and a small EPS guidance reduction (share count related) on the heels of MGLN's 50%+ surge (vs S&P's +10%) since early November are causing shares to pull back today (down 7-8% vs S&P's -0.2%). 4Q16 revenue was soft, but that's largely due to a short delay in starting new work. We think fundamentals remain broadly strong and remain Buy rated, but we modestly reduce our earnings projections and PT for higher Pharmacy uncertainty." (2/24/2017)

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:

  • Barry Michael Smith, Executive Chairman of the Board, Chief Executive Officer (Age 64)
  • Mostafa Kamal, Chief Executive Officer of Magellan Rx Management (Age 36)
  • Sanjeev K. Srivastava, Chief Executive Officer - Magellan Healthcare (Age 49)
  • Caskie R. Lewis-Clapper, Chief Human Resource Officer (Age 52)
  • Daniel N. Gregoire, General Counsel, Secretary (Age 61)
  • William J. McBride, Lead Independent Director (Age 72)
  • John O. Agwunobi M.D., Independent Director (Age 52)
  • Eran Broshy, Independent Director (Age 58)
  • Michael S. Diament, Independent Director (Age 48)
  • Perry G. Fine M.D., Independent Director (Age 64)

Who owns Magellan Health stock?

Magellan Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (8.25%), Orbimed Advisors LLC (3.67%), Fisher Asset Management LLC (3.02%), JPMorgan Chase & Co. (2.66%), Hood River Capital Management LLC (2.11%) and Victory Capital Management Inc. (1.92%). Company insiders that own Magellan Health stock include Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Who sold Magellan Health stock? Who is selling Magellan Health stock?

Magellan Health's stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, BNP Paribas Arbitrage SA, JPMorgan Chase & Co., Citadel Advisors LLC, Dean Investment Associates LLC, Russell Investments Group Ltd., Bank of New York Mellon Corp and Ameriprise Financial Inc.. Company insiders that have sold Magellan Health company stock in the last year include Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health.

Who bought Magellan Health stock? Who is buying Magellan Health stock?

Magellan Health's stock was acquired by a variety of institutional investors in the last quarter, including Hood River Capital Management LLC, Wells Fargo & Company MN, Hillcrest Asset Management LLC, ClariVest Asset Management LLC, Nordea Investment Management AB, Smith Asset Management Group LP, Shell Asset Management Co. and Chicago Equity Partners LLC. View Insider Buying and Selling for Magellan Health.

How do I buy Magellan Health stock?

Shares of Magellan Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of Magellan Health stock can currently be purchased for approximately $83.65.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.99 billion and generates $4.84 billion in revenue each year. The company earns $77.87 million in net income (profit) each year or $3.79 on an earnings per share basis. Magellan Health employs 9,700 workers across the globe.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  191 (Vote Underperform)
Total Votes:  386
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Magellan Health (NASDAQ:MGLN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 0 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $81.25 (2.87% downside)

Consensus Price Target History for Magellan Health (NASDAQ:MGLN)

Price Target History for Magellan Health (NASDAQ:MGLN)

Analysts' Ratings History for Magellan Health (NASDAQ:MGLN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/13/2017Jefferies Group LLCReiterated RatingBuy$94.00N/AView Rating Details
9/22/2017KeyCorpReiterated RatingBuy$89.00LowView Rating Details
6/25/2017Leerink SwannReiterated RatingOutperform$68.00 -> $73.00LowView Rating Details
11/23/2016Barclays PLCBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
(Data available from 11/22/2015 forward)

Earnings

Earnings History and Estimates Chart for Magellan Health (NASDAQ:MGLN)

Earnings by Quarter for Magellan Health (NASDAQ:MGLN)

Earnings History by Quarter for Magellan Health (NASDAQ MGLN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3 2017$1.40$1.64$1.49 billion$1.42 billionViewN/AView Earnings Details
7/28/2017Q2 2017$0.94$0.46$1.40 billion$1.42 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.70$0.74$1.33 billion$1.31 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.12 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.27 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Magellan Health (NASDAQ:MGLN)
2017 EPS Consensus Estimate: $4.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.66$0.87$0.75
Q2 20173$0.85$0.92$0.89
Q3 20173$0.86$1.33$1.06
Q4 20173$1.44$1.62$1.56
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Magellan Health (NASDAQ:MGLN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Magellan Health (NASDAQ MGLN)

Insider Ownership Percentage: 5.00%
Institutional Ownership Percentage: 93.21%
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)

Insider Trades by Quarter for Magellan Health (NASDAQ MGLN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2017Daniel N GregoireGeneral CounselSell9,369$89.20$835,714.80View SEC Filing  
11/1/2017Mostafa KamalCEOSell1,154$92.00$106,168.00View SEC Filing  
10/4/2017Daniel N GregoireGeneral CounselSell12,475$88.02$1,098,049.50View SEC Filing  
10/3/2017Jeffrey N WestSVPSell30,021$87.31$2,621,133.51View SEC Filing  
10/2/2017Jeffrey N WestSVPSell19,007$86.22$1,638,783.54View SEC Filing  
9/29/2017Jeffrey N WestSVPSell18,511$86.18$1,595,277.98View SEC Filing  
9/28/2017Jeffrey N WestSVPSell25,316$85.85$2,173,378.60View SEC Filing  
9/28/2017Mostafa KamalCEOSell4,848$85.76$415,764.48View SEC Filing  
9/27/2017Daniel N GregoireGeneral CounselSell35,658$85.17$3,036,991.86View SEC Filing  
9/27/2017Jeffrey N WestSVPSell19,921$85.30$1,699,261.30View SEC Filing  
9/27/2017Mostafa KamalCEOSell19,126$85.33$1,632,021.58View SEC Filing  
9/15/2017Daniel N GregoireGeneral CounselSell20,465$83.05$1,699,618.25View SEC Filing  
9/15/2017Mostafa KamalCEOSell2,961$84.00$248,724.00View SEC Filing  
9/13/2017Daniel N GregoireGeneral CounselSell14,096$83.06$1,170,813.76View SEC Filing  
9/13/2017Mostafa KamalCEOSell604$83.00$50,132.00View SEC Filing  
9/11/2017Daniel N GregoireGeneral CounselSell2,400$83.00$199,200.00View SEC Filing  
9/11/2017Mostafa KamalCEOSell670$83.00$55,610.00View SEC Filing  
9/8/2017Mostafa KamalCEOSell6,267$81.53$510,948.51View SEC Filing  
9/7/2017Mostafa KamalCEOSell2,190$81.07$177,543.30View SEC Filing  
7/25/2017Daniel N GregoireGeneral CounselSell4,559$80.68$367,820.12View SEC Filing  
7/24/2017Daniel N GregoireGeneral CounselSell33,574$80.11$2,689,613.14View SEC Filing  
7/20/2017Daniel N GregoireGeneral CounselSell16,073$80.06$1,286,804.38View SEC Filing  
7/20/2017Jeffrey N WestSVPSell1,109$80.01$88,731.09View SEC Filing  
7/17/2017Jeffrey N WestSVPSell28,514$80.07$2,283,115.98View SEC Filing  
7/14/2017Daniel N GregoireGeneral CounselSell14,114$80.11$1,130,672.54View SEC Filing  
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.72View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.00View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.30View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.30View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.70View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.82View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.00View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.50View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.20View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.77View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.33View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.05View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.00View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.00View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.34View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.00View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.21View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.00View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.25View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.00View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.10View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.59View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.00View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.00View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.71View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Magellan Health (NASDAQ MGLN)

Source:
DateHeadline
A Magellan Collaboration With Talkspace Confuses Patients And Increases RiskA Magellan Collaboration With Talkspace Confuses Patients And Increases Risk
www.forbes.com - November 22 at 5:05 AM
Magellan Health Leverages Talkspaces Messaging Therapy For Magellans Employer ClientsMagellan Health Leverages Talkspace's Messaging Therapy For Magellan's Employer Clients
www.thestreet.com - November 15 at 6:22 AM
Magellan Health Announces 2018 Financial Guidance CallMagellan Health Announces 2018 Financial Guidance Call
finance.yahoo.com - November 15 at 6:22 AM
Magellan Health, Inc. (MGLN) Expected to Post Earnings of $2.30 Per ShareMagellan Health, Inc. (MGLN) Expected to Post Earnings of $2.30 Per Share
www.americanbankingnews.com - November 11 at 10:22 AM
ETFs with exposure to Magellan Health, Inc. : November 6, 2017ETFs with exposure to Magellan Health, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 6:51 AM
Magellan Health Leverages Talkspace’s Messaging Therapy for Magellan’s Employer ClientsMagellan Health Leverages Talkspace’s Messaging Therapy for Magellan’s Employer Clients
finance.yahoo.com - November 7 at 6:51 AM
Magellan Health, Inc. (MGLN) Receives Average Rating of "Buy" from BrokeragesMagellan Health, Inc. (MGLN) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 6 at 6:11 PM
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted in Texas Church ShootingMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted in Texas Church Shooting
finance.yahoo.com - November 6 at 2:11 AM
Magellan Health, Inc. :MGLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017Magellan Health, Inc. :MGLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 5:43 PM
Insider Selling: Magellan Health, Inc. (MGLN) CEO Sells 1,154 Shares of StockInsider Selling: Magellan Health, Inc. (MGLN) CEO Sells 1,154 Shares of Stock
www.americanbankingnews.com - November 3 at 4:06 AM
Magellan Health, Inc. (MGLN) General Counsel Daniel N. Gregoire Sells 9,369 SharesMagellan Health, Inc. (MGLN) General Counsel Daniel N. Gregoire Sells 9,369 Shares
www.americanbankingnews.com - November 3 at 4:04 AM
Magellan Health, Inc. (MGLN) Announces  Earnings ResultsMagellan Health, Inc. (MGLN) Announces Earnings Results
www.americanbankingnews.com - November 2 at 6:44 PM
Magellan Health Reports Third Quarter 2017 Financial ResultsMagellan Health Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 2 at 6:23 AM
Magellan Health beats 3Q profit forecastsMagellan Health beats 3Q profit forecasts
finance.yahoo.com - November 2 at 6:23 AM
Magellan Health, Inc. to Host Earnings CallMagellan Health, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 6:23 AM
Edited Transcript of MGLN earnings conference call or presentation 1-Nov-17 2:00pm GMTEdited Transcript of MGLN earnings conference call or presentation 1-Nov-17 2:00pm GMT
finance.yahoo.com - November 2 at 6:23 AM
Magellan Health, Inc. (MGLN) Releases FY17 Earnings GuidanceMagellan Health, Inc. (MGLN) Releases FY17 Earnings Guidance
www.americanbankingnews.com - November 1 at 9:58 AM
Magellan Health Closes on Acquisition of Senior Whole HealthMagellan Health Closes on Acquisition of Senior Whole Health
finance.yahoo.com - November 1 at 6:15 AM
Reviewing Magellan Health (MGLN) and Its CompetitorsReviewing Magellan Health (MGLN) and Its Competitors
www.americanbankingnews.com - November 1 at 1:20 AM
Comparing Magellan Health (MGLN) & The CompetitionComparing Magellan Health (MGLN) & The Competition
www.americanbankingnews.com - October 31 at 5:24 PM
Magellan Health, Inc. (MGLN) to Release Earnings on TuesdayMagellan Health, Inc. (MGLN) to Release Earnings on Tuesday
www.americanbankingnews.com - October 31 at 4:22 AM
Head-To-Head Survey: Magellan Health (MGLN) & Its CompetitorsHead-To-Head Survey: Magellan Health (MGLN) & Its Competitors
www.americanbankingnews.com - October 30 at 9:28 AM
Contrasting Magellan Health (MGLN) & Its PeersContrasting Magellan Health (MGLN) & Its Peers
www.americanbankingnews.com - October 30 at 8:22 AM
Comparing Magellan Health (MGLN) and Its CompetitorsComparing Magellan Health (MGLN) and Its Competitors
www.americanbankingnews.com - October 30 at 1:22 AM
Critical Contrast: Magellan Health (MGLN) & Its RivalsCritical Contrast: Magellan Health (MGLN) & Its Rivals
www.americanbankingnews.com - October 28 at 1:28 PM
Magellan Health Clears Key Benchmark, Hitting 80-Plus RS RatingMagellan Health Clears Key Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - October 27 at 7:21 AM
Critical Analysis: Magellan Health (MGLN) and The CompetitionCritical Analysis: Magellan Health (MGLN) and The Competition
www.americanbankingnews.com - October 26 at 11:36 AM
Magellan Health (MGLN) versus Its Competitors Critical ReviewMagellan Health (MGLN) versus Its Competitors Critical Review
www.americanbankingnews.com - October 24 at 6:30 PM
Reviewing Magellan Health (MGLN) & Its RivalsReviewing Magellan Health (MGLN) & Its Rivals
www.americanbankingnews.com - October 24 at 4:38 PM
Magellan Health to Participate in Bernstein Healthcare Services Disruptors ConferenceMagellan Health to Participate in Bernstein Healthcare Services Disruptors Conference
finance.yahoo.com - October 24 at 5:41 AM
Contrasting Magellan Health (MGLN) & Its RivalsContrasting Magellan Health (MGLN) & Its Rivals
www.americanbankingnews.com - October 22 at 2:08 PM
Magellan Health, Inc. (MGLN) Expected to Announce Earnings of $1.42 Per ShareMagellan Health, Inc. (MGLN) Expected to Announce Earnings of $1.42 Per Share
www.americanbankingnews.com - October 22 at 12:32 PM
Magellan Health (MGLN) & Its Competitors Financial ReviewMagellan Health (MGLN) & Its Competitors Financial Review
www.americanbankingnews.com - October 22 at 12:24 AM
Reviewing Magellan Health (MGLN) & The CompetitionReviewing Magellan Health (MGLN) & The Competition
www.americanbankingnews.com - October 20 at 12:32 AM
Comparing Magellan Health (MGLN) and Its PeersComparing Magellan Health (MGLN) and Its Peers
www.americanbankingnews.com - October 18 at 12:36 PM
Critical Analysis: Magellan Health (MGLN) & Its RivalsCritical Analysis: Magellan Health (MGLN) & Its Rivals
www.americanbankingnews.com - October 16 at 8:30 PM
Magellan Health, Inc. (MGLN) Receives Buy Rating from Jefferies Group LLCMagellan Health, Inc. (MGLN) Receives Buy Rating from Jefferies Group LLC
www.americanbankingnews.com - October 14 at 7:40 AM
Magellan Health, Inc. (MGLN) Receives Consensus Rating of "Buy" from AnalystsMagellan Health, Inc. (MGLN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 12 at 4:48 PM
Corporate News Blog - Magellan Health Announces the Receipt of All Necessary Regulatory Approvals for Acquiring Senior Whole HealthCorporate News Blog - Magellan Health Announces the Receipt of All Necessary Regulatory Approvals for Acquiring Senior Whole Health
finance.yahoo.com - October 12 at 6:51 AM
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by California WildfiresMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by California Wildfires
finance.yahoo.com - October 10 at 8:17 PM
Magellan Health (MGLN) & The Competition Financial SurveyMagellan Health (MGLN) & The Competition Financial Survey
www.americanbankingnews.com - October 9 at 6:28 PM
Magellan Health Receives Regulatory Approvals to Acquire Senior Whole HealthMagellan Health Receives Regulatory Approvals to Acquire Senior Whole Health
finance.yahoo.com - October 9 at 4:07 PM
Reviewing Magellan Health (MGLN) and The CompetitionReviewing Magellan Health (MGLN) and The Competition
www.americanbankingnews.com - October 8 at 6:30 AM
Magellan Health (MGLN) versus Its Competitors Head-To-Head ContrastMagellan Health (MGLN) versus Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - October 5 at 8:24 PM
Insider Selling: Magellan Health, Inc. (MGLN) General Counsel Sells 12,475 Shares of StockInsider Selling: Magellan Health, Inc. (MGLN) General Counsel Sells 12,475 Shares of Stock
www.americanbankingnews.com - October 5 at 1:28 PM
$1.49 Billion in Sales Expected for Magellan Health, Inc. (MGLN) This Quarter$1.49 Billion in Sales Expected for Magellan Health, Inc. (MGLN) This Quarter
www.americanbankingnews.com - October 5 at 3:38 AM
Magellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 30,021 SharesMagellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 30,021 Shares
www.americanbankingnews.com - October 4 at 7:20 PM
Insider Selling: Magellan Health, Inc. (MGLN) SVP Sells 19,007 Shares of StockInsider Selling: Magellan Health, Inc. (MGLN) SVP Sells 19,007 Shares of Stock
www.americanbankingnews.com - October 3 at 10:28 PM
Magellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 18,511 SharesMagellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 18,511 Shares
www.americanbankingnews.com - October 3 at 10:28 PM
Magellan Health, Inc. (MGLN) Expected to Announce Earnings of $1.46 Per ShareMagellan Health, Inc. (MGLN) Expected to Announce Earnings of $1.46 Per Share
www.americanbankingnews.com - October 3 at 6:20 PM

Social Media

Financials

Chart

Magellan Health (NASDAQ MGLN) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.